Mark J. Gergen - Mar 1, 2024 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Executive Chairman, Director
Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Mar 1, 2024
Transactions value $
-$141,068
Form type
4
Date filed
3/4/2024, 05:18 PM
Previous filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Tax liability -$141K -34.2K -4.98% $4.13 651K Mar 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on March 1, 2023.